Luminex Corporation (LMNX) Return on Investment ROI from the first quarter of 2021 to first quarter of 2020 and for the year 2021, average high and low, overall ranking from Mar 31 2021 to Mar 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Luminex Corporation  (NASDAQ: LMNX)


Luminex's ROI from its first quarter of 2021 to the first quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Luminex's ROI in the first quarter of 2021?
Luminex Corporation achieved a return on average invested assets (ROI) of 10.21 % in its first quarter of 2021, this is above LMNX's average return on investment of 6.88%.
Luminex Corporation invested over the 12 months ending in its first quarter of 2021 $608 million

ROI has improved compared to 6.46% in the fourth quarter of 2020, due to net income growth.

Within the Healthcare sector 90 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2021 quarter, so far to 717, from total ROI ranking in the fourth quarter of 2020 at 1081.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Investment Change TTM 25.32 % 38.92 % 26.77 % 12.23 % 1.18 %
Y / Y Net Income Change TTM 846.62 % 286.82 % 425.25 % 355.47 % 2.04 %
Investment (TTM) in Millions 203 738 770 721 483
Return On Investment (TTM) 10.21 % 6.46 % 6.78 % 6.24 % 1.35 %
LMNX's Overall Ranking # 717 # 1081 # 1406 # #
Seq. Investment Change TTM -10.31 % 10.26 % 13.26 % 11.89 % -0.58 %
Seq. Net Income Change TTM 41.73 % 5.01 % 23 % 417.06 % -42.08 %
Net Income (TTM) in Millions 62 44 42 34 7

LMNX Company Profile >> Back to LMNX Roi Comparisons >> See Annual LMNX Return On Investment



Return On Investment LMNX's Ranking
Within: No.
Industry # 21
Sector # 91
Overall # 717

Return On Investment Statistics
High Average Low
14.54 %
6.88 %
1.17 %
(March 31, 2015)   (Dec 31 2019)







Financial Statements
Luminex's I. Quarter Investments $ 203 Millions LMNX's Balance sheet
Luminex's I. Quarter Income $ 20 Millions Quarterly LMNX's Income Statement
LMNX's Income by Division See LMNX's Income by Division


LMNX Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 738 486 474 445 411
Y / Y Investment Growth 51.96 % 2.5 % 6.41 % 8.47 % 9.38 %
Net Income in Millions 44 6 19 29 14
Y / Y Net Income Growth 664.76 % -69.05 % -35.95 % 109.16 % -62.52 %
Annual Return On Investment 5.94 % 1.18 % 3.91 % 6.49 % 3.37 %


Annual Roi Comment
In the fiscal year 2020 ROI improved to 5.94 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LMNX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LMNX's Competitors
Subscribers only: Roi for Luminex's Suppliers
Subscribers only: Return On Investment for LMNX's Customers

Other Ratios
LMNX's Roa LMNX's Inventory Turnover Ratio LMNX's Growth Rates LMNX's Dividend Statistics
LMNX's Profitability Ratios LMNX's Asset Turnover Ratio LMNX's Dividend Growth
LMNX's Roe LMNX's Valuation Ratios LMNX's Financial Strength Ratios LMNX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2021, within Healthcare Sector ROI
Lifevantage Corp  28.00 %
Chemed Corporation  27.90 %
Pro dex Inc   26.68 %
Lakeland Industries Inc   26.60 %
Infusystem Holdings Inc  26.60 %
Blueprint Medicines Corporation  24.72 %
Oramed Pharmaceuticals Inc  24.42 %
Elite Health Systems Inc   23.61 %
Organon and Co   23.59 %
Maravai Lifesciences Holdings Inc   23.48 %
Meridian Bioscience Inc   23.25 %
Seagen Inc   23.06 %
Halozyme Therapeutics Inc   22.43 %
Bionexus Gene Lab Corp   22.29 %
Elite Pharmaceuticals Inc   21.85 %
Harrow Inc   21.00 %
23andme Holding Co  20.92 %
Organogenesis Holdings Inc   20.49 %
Corcept Therapeutics Inc  20.06 %
West Pharmaceutical Services Inc   19.45 %
Eli Lilly And Company  18.47 %
Abiomed Inc   17.92 %
Waters Corporation  17.90 %
Amedisys Inc  17.68 %
Revvity Inc  17.42 %
Voyager Therapeutics Inc   17.39 %
Moderna Inc   17.38 %
Incyte Corporation  16.87 %
Rayont Inc   16.79 %
Healthcare Services Group Inc   16.70 %

Date modified: 2026-09-26T07:16:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.